Foot-and-mouth disease
| dc.creator | FAO | |
| dc.date | 2024-04-29T13:35:19Z | |
| dc.date | 2024-04-29T13:35:19Z | |
| dc.date | 2024 | |
| dc.date | 2024-04-29T13:29:22Z | |
| dc.date.accessioned | 2026-06-28T00:54:28Z | |
| dc.description | During the last three months, the World Reference Laboratory for Foot-and-Mouth Disease (WRLFMD) has reported test results for samples received from Israel, Pakistan, Palestine, Thailand and Türkiye. There have also been new sequence submissions from Algeria (ANSES, France), Botswana (BVI, Botswana), Ethiopia (BVI, Botswana) and India. Data for samples from Türkiye demonstrate how the SAT2/XIV topotype has recently spread within Anatolia, where 30 further outbreaks due to this lineage have been detected in the country during this quarter. Elsewhere in the Near East, samples from the O/ME-SA/PanAsia-2ANT-10 sub-lineage have been detected in Israel and Palestine. Data presented at the GFRA meeting in November indicate that viruses from the A/EURO-SA lineage continue to be detected within Egypt. Vaccine matching is now underway using a selection of historical viruses from South America (Argentina, Plurinational State of Bolivia, Brazil, Ecuador, Paraguay, Uruguay, and Bolivarian Republic of Venezuela) which have been provided by PANAFTOSA (Brazil) to help understand whether foot-and-mouth disease vaccines will provide protection against this exotic lineage that was first detected during 2022 (as well as O/EURO/SA that was also detected in Egypt in 2022). This report also presents analyses of sequences for diverse serotype Asia 1 viruses circulating in India, representing different two named genotypes including the first detection of genotype IX in the country. | |
| dc.format | 41 p. | |
| dc.format | application/pdf | |
| dc.identifier | https://openknowledge.fao.org/handle/20.500.14283/cd0331en | |
| dc.identifier.uri | http://hdl.handle.net/123456789/322194 | |
| dc.language | English | |
| dc.publisher | FAO ; | |
| dc.rights | FAO | |
| dc.rights | CC BY NC SA 3.0 IGO | |
| dc.title | Foot-and-mouth disease | |
| dc.title | Quarterly report, October–December 2023 | |
| dc.type | Booklet |